11-108158957-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_002519.3(NPAT):​c.4269G>A​(p.Leu1423Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000622 in 1,446,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

NPAT
NM_002519.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.783

Publications

0 publications found
Variant links:
Genes affected
NPAT (HGNC:7896): (nuclear protein, coactivator of histone transcription) Enables protein C-terminus binding activity; transcription coactivator activity; and transcription corepressor activity. Involved in positive regulation of transcription by RNA polymerase II and regulation of transcription involved in G1/S transition of mitotic cell cycle. Located in Cajal body; Gemini of coiled bodies; and cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
NPAT Gene-Disease associations (from GenCC):
  • colorectal cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 11-108158957-C-T is Benign according to our data. Variant chr11-108158957-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1739224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.783 with no splicing effect.
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPATNM_002519.3 linkc.4269G>A p.Leu1423Leu synonymous_variant Exon 18 of 18 ENST00000278612.9 NP_002510.2 Q14207
NPATNM_001321307.1 linkc.4290G>A p.Leu1430Leu synonymous_variant Exon 18 of 18 NP_001308236.1
NPATXM_011542854.3 linkc.4296G>A p.Leu1432Leu synonymous_variant Exon 18 of 18 XP_011541156.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPATENST00000278612.9 linkc.4269G>A p.Leu1423Leu synonymous_variant Exon 18 of 18 1 NM_002519.3 ENSP00000278612.8 Q14207
NPATENST00000850623.1 linkc.4269G>A p.Leu1423Leu synonymous_variant Exon 18 of 18 ENSP00000520908.1
NPATENST00000530859.1 linkn.1642G>A non_coding_transcript_exon_variant Exon 5 of 5 2
NPATENST00000530926.1 linkn.426G>A non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000622
AC:
9
AN:
1446710
Hom.:
0
Cov.:
27
AF XY:
0.00000694
AC XY:
5
AN XY:
720796
show subpopulations
African (AFR)
AF:
0.000121
AC:
4
AN:
33192
American (AMR)
AF:
0.00
AC:
0
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26004
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39470
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85992
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1100454
Other (OTH)
AF:
0.0000834
AC:
5
AN:
59924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000756
Asia WGS
AF:
0.000867
AC:
3
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 12, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Feb 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
5.9
DANN
Benign
0.67
PhyloP100
0.78
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550347845; hg19: chr11-108029684; API